Cargando…

Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats

Vaccination against the highly abused prescription opioid oxycodone has shown pre-clinical efficacy for blocking oxycodone effects. The current study further evaluated a candidate vaccine composed of oxycodone derivatized at the C6 position (6OXY) conjugated to the native keyhole limpet hemocyanin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pravetoni, Marco, Vervacke, Jeffrey S., Distefano, Mark D., Tucker, Ashli M., Laudenbach, Megan, Pentel, Paul R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010527/ https://www.ncbi.nlm.nih.gov/pubmed/24797666 http://dx.doi.org/10.1371/journal.pone.0096547

Ejemplares similares

Effects of an Oxycodone Conjugate Vaccine on Oxycodone Self-Administration and Oxycodone-Induced Brain Gene Expression in Rats
por: Pravetoni, Marco, et al.
Publicado: (2014)

Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse
por: Raleigh, M. D., et al.
Publicado: (2017)

Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders
por: Crouse, Bethany, et al.
Publicado: (2020)

Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose
por: Laudenbach, Megan, et al.
Publicado: (2018)

Synthesis of Site-Specific DNA–Protein Conjugates and Their Effects on DNA Replication
por: Yeo, Jung Eun, et al.
Publicado: (2014)

Immunogenicity of Individual Vaccine Components in a Bivalent Nicotine Vaccine Differ According to Vaccine Formulation and Administration Conditions
por: Cornish, Katherine E., et al.
Publicado: (2013)

Antibody-drug conjugates: beyond current approvals and potential future strategies
por: Menon, Siddharth, et al.
Publicado: (2022)

Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis
por: Lazzari, Marzia, et al.
Publicado: (2015)

Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge
por: Powers, Noah, et al.
Publicado: (2023)

Diazirine-Containing Photoactivatable Isoprenoid: Synthesis and Application in Studies with Isoprenylcysteine Carboxyl Methyltransferase
por: Vervacke, Jeffrey S., et al.
Publicado: (2014)

Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
por: Illenberger, Jessica M., et al.
Publicado: (2023)

Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin
por: Masri, Abdulkader, et al.
Publicado: (2018)

Efficacy of Oxycodone for Dyspnea in End-stage Heart Failure with Renal Insufficiency
por: Tanaka, Masayuki, et al.
Publicado: (2017)

A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models
por: Crouse, Bethany, et al.
Publicado: (2023)

Use of Oxycodone in Pain Management
por: Moradi, Mohammad, et al.
Publicado: (2012)

Epidural Oxycodone for Acute Pain
por: Piirainen, Panu, et al.
Publicado: (2022)

Distinct Synaptic Vesicle Proteomic Signatures Associated with Pre- and Post-Natal Oxycodone-Exposure
por: Odegaard, Katherine E., et al.
Publicado: (2022)

Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial
por: Lee, Kyung-Hee, et al.
Publicado: (2017)

A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice
por: Miller, Shannon M., et al.
Publicado: (2023)

Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development
por: Hammood, Manar, et al.
Publicado: (2021)

Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
por: Kokki, Merja, et al.
Publicado: (2016)

Incubation of Oxycodone Craving Following Adult-Onset and Adolescent-Onset Oxycodone Self-Administration in Male Rats
por: Altshuler, Rachel D., et al.
Publicado: (2021)

Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats
por: Hinds, Nicole M., et al.
Publicado: (2023)

Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats
por: Hinds, Nicole M., et al.
Publicado: (2023)

Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone
por: Manandhar, Preeti, et al.
Publicado: (2022)

Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350
por: Poulsen, Jakob L, et al.
Publicado: (2018)

Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study
por: Webster, Lynn R., et al.
Publicado: (2019)

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
por: Tong, Juliana T. W., et al.
Publicado: (2021)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

A Holistic Systems Approach to Characterize the Impact of Pre- and Post-natal Oxycodone Exposure on Neurodevelopment and Behavior
por: Odegaard, Katherine E., et al.
Publicado: (2021)

Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge
por: Stone, Addison E., et al.
Publicado: (2021)

Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice
por: Ueberall, Michael A, et al.
Publicado: (2016)

Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking
por: Wilkinson, Courtney S., et al.
Publicado: (2023)

Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking
por: Wilkinson, Courtney S., et al.
Publicado: (2023)

A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐naloxone (up to 160/80 mg daily) vs oxycodone PR
por: Dupoiron, D., et al.
Publicado: (2017)

Oxycodone Controlled Release in Cancer Pain Management
por: Biancofiore, Giuseppe
Publicado: (2006)

An Unusual Case of Serotonin Syndrome with Oxycodone and Citalopram
por: Walter, Clare, et al.
Publicado: (2012)

The place of oxycodone/naloxone in chronic pain management
por: Leppert, Wojciech
Publicado: (2013)

Advances in the clinical application of oxycodone in the perioperative period
por: Chen, Hong-Yang, et al.
Publicado: (2022)

Ketogenic diet enhances the effects of oxycodone in mice
por: Trinko, R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1es803jbtvicuigki6ffndm5f5